Discussion about this post

User's avatar
Brother🍓 Strawberry's avatar

Step1-Identify cluster of deaths.

Step2-Blame a phantom based on mass, flawed, unverifiable testing of a population for RNA fragments presumed synonymous with infection by the phantom.

Silence dissent.

Step3-Expand disease definition to include illness previously recognized caused by other or unknown causes but occur in the presence of the phantom thus increasing “case count”.

Silence dissent

Step4-Prescribe toxic treatment like AZT/intubation to increase death count and blame those deaths on the phantom not the treatment.

Silence dissent

Step5-Insist lifetime less toxic, slower killing “cocktail therapy”/“vaccine boosters” are only protection/defense against often undetectable phantom.

Silence dissent

 SARS-cov2/covid19 is hiv/AIDS2.0.

  Both are a LIE.

If hepatitis-c is “cured” when no virus is detected why does an AIDS patient with undetectable viral load and t-cell count 600+ require lifetime treatment with a balanced “cocktail” of slow killing, toxic chemotherapeutic drugs that have known side effects that mirror the definition of AIDS?

If an AIDS patient with undetectable viral load went for an AIDS test and didn’t tell that they were previously hiv positive they would be told they were not infected and do not need treatment but would be encouraged to begin the recently released hiv vaccine that requires injection every two months. For the rest of your sexually active life.

As with any profit based business, ensuring return customers is vital for success.

  If as is claimed, hiv remains latent, inactive, not reproducing and undetectable in hidden reservoirs how can anyone ever be certain they are not infected and the virus isn’t just inactive and undetectable in hidden reservoirs?

 Why isn’t everyone on anti-hiv treatment? Just in case.

For the common good.

How are people not seeing through this bs?

Some of us saw it coming.

Expand full comment
Caitlin PR's avatar

Looking at injectable drugs, there's a pretty clear economic and social rationale for getting us hooked. This is ChatGPT's answer to "Explain to me why injectable medications are considered lucrative for the healthcare industry" and it matches with research I have done directly.

Injectable medications are considered lucrative for the healthcare industry for several key reasons:

1. Higher Pricing and Reimbursement

Premium pricing: Injectable drugs, especially biologics and specialty medications, are often priced significantly higher than oral medications. This is due to their complex manufacturing processes, clinical value, and the lack of generic competition.

Reimbursement incentives: Many injectables are covered under the medical benefit (rather than the pharmacy benefit), which may allow for markups and provider-administered billing (e.g., “buy and bill” model), especially in outpatient or hospital settings.

2. Patent Protection and Market Exclusivity

Injectable biologics are often protected by longer and more complex patent portfolios, delaying biosimilar competition.

Fewer companies can make biosimilars due to the high cost and regulatory barriers for biologic development, extending the brand’s market dominance.

3. Provider-Administered Revenue

When injections are given in clinical settings (e.g., hospitals, outpatient infusion centers, specialty practices), providers often charge administration fees and can bill for the drug itself at a markup. This creates a revenue stream for hospitals and physicians.

This model incentivizes the use of higher-cost injectables over lower-cost oral alternatives.

4. Chronic Use and Repeat Dosing

Many injectables are used for chronic diseases (e.g., rheumatoid arthritis, multiple sclerosis, certain cancers), requiring regular administration—monthly, weekly, or even more frequently.

This ensures steady, repeat revenue for pharmaceutical companies and the healthcare system.

5. Specialty Pharmacy and Distribution Channels

Injectable drugs are typically distributed through specialty pharmacies or providers, which command high margins and offer services like cold-chain logistics, prior authorization support, and patient monitoring.

These services further embed these drugs into high-value healthcare networks.

Expand full comment
6 more comments...

No posts